{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:59:11Z","timestamp":1791838751798,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["The medical writing was funded by Boehringer Ingelheim"],"award-info":[{"award-number":["The medical writing was funded by Boehringer Ingelheim"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40257-021-00654-z","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:02:48Z","timestamp":1642752168000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Clinical Course and Characteristics of Generalized Pustular Psoriasis"],"prefix":"10.1007","volume":"23","author":[{"given":"Siew Eng","family":"Choon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"11","key":"654_CR1","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, K\u00f6ks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"654_CR2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/1744666X.2019.1648209","volume":"15","author":"MJ Gooderham","year":"2019","unstructured":"Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907\u201319.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"654_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ijd.12070","volume":"53","author":"SE Choon","year":"2014","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676\u201384.","journal-title":"Int J Dermatol"},{"issue":"12","key":"654_CR4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","volume":"80","author":"H Baker","year":"1968","unstructured":"Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80(12):771\u201393.","journal-title":"Br J Dermatol"},{"issue":"9","key":"654_CR5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archderm.1991.01680080075005","volume":"127","author":"BD Zelickson","year":"1991","unstructured":"Zelickson BD, Muller SA. Generalized pustular psoriasis: a review of 63 cases. Arch Dermatol. 1991;127(9):1339\u201345.","journal-title":"Arch Dermatol"},{"key":"654_CR6","first-page":"37","volume":"9","author":"K Ly","year":"2019","unstructured":"Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis (Auckl). 2019;9:37\u201342.","journal-title":"Psoriasis (Auckl)."},{"issue":"4","key":"654_CR7","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.burns.2014.01.003","volume":"40","author":"KM Varman","year":"2014","unstructured":"Varman KM, Namias N, Schulman CI, Pizano LR. Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit: a review of clinical features and new therapeutics. Burns. 2014;40(4):e35\u20139.","journal-title":"Burns"},{"issue":"2","key":"654_CR8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.20305","volume":"40","author":"M Viguier","year":"2004","unstructured":"Viguier M, Allez M, Zagdanski A-M, Bertheau P, de Kerviler E, Rybojad M, et al. High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract. Hepatology. 2004;40(2):452\u20138.","journal-title":"Hepatology"},{"issue":"3 Suppl.","key":"654_CR9","doi-asserted-by":"crossref","first-page":"AB20","DOI":"10.1016\/j.jaad.2021.06.107","volume":"85","author":"H Bachelez","year":"2021","unstructured":"Bachelez H, Massol J, de Pouvourville G, Gloede T, Medina P, Esser D, et al. Characterization of flares in patients with generalized pustular psoriasis: a population-based study from the French National Health Data System database (SNDS). J Am Acad Dermatol. 2021;85(3 Suppl.):AB20.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"654_CR10","first-page":"669","volume":"16","author":"F Augey","year":"2006","unstructured":"Augey F, Renaudier P, Nicolas J-F. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16(6):669\u201373.","journal-title":"Eur J Dermatol"},{"issue":"7","key":"654_CR11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1346-8138.12863","volume":"42","author":"H Jin","year":"2015","unstructured":"Jin H, Cho H-H, Kim W-J, Mun J-H, Song M, Kim H-S, et al. Clinical features and course of generalized pustular psoriasis in Korea. J Dermatol. 2015;42(7):674\u20138.","journal-title":"J Dermatol"},{"key":"654_CR12","unstructured":"Fujita H, Gooderham M, Romiti R. Diagnosis of generalized pustular psoriasis. Am J Clin Dermatol. 2021; JCDA-D-21-00444."},{"key":"654_CR13","unstructured":"Krueger J, Puig L, Tha\u00e7i D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol. 2021; JCDA-D-21-00447."},{"issue":"1","key":"654_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01910970","volume":"99","author":"LR von Zumbusch","year":"1909","unstructured":"von Zumbusch LR. Psoriasis und pustul\u00f6ses exanthem. Arch Fur Dermatol. 1909;99(1):335\u201346.","journal-title":"Arch Fur Dermatol."},{"issue":"1","key":"654_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1470.2002.00026.x","volume":"19","author":"PB Liao","year":"2002","unstructured":"Liao PB, Rubinson R, Howard R, Sanchez G, Frieden IJ. Annular pustular psoriasis: most common form of pustular psoriasis in children: report of three cases and review of the literature. Ped Dermatol. 2002;19(1):19\u201325.","journal-title":"Ped Dermatol."},{"issue":"5","key":"654_CR16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archderm.1981.01650050069029","volume":"117","author":"DJ Adler","year":"1981","unstructured":"Adler DJ, Rower JM, Hashimoto K. Annular pustular psoriasis. Arch Dermatol. 1981;117(5):313\u20134.","journal-title":"Arch Dermatol"},{"issue":"4","key":"654_CR17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ijd.13489","volume":"56","author":"B-W Lau","year":"2017","unstructured":"Lau B-W, Lim D-Z, Capon F, Barker JN, Choon S-E. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2017;56(4):392\u20139.","journal-title":"Int J Dermatol"},{"issue":"6","key":"654_CR18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.18203","volume":"181","author":"E Sbidian","year":"2019","unstructured":"Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, et al. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol. 2019;181(6):1304\u20136.","journal-title":"Br J Dermatol"},{"issue":"6","key":"654_CR19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archderm.1969.01610240029004","volume":"99","author":"M Ogawa","year":"1969","unstructured":"Ogawa M, Baughman RD, Clendenning WE. Generalized pustular psoriasis: induction by topical use of coal tar. Arch Dermatol. 1969;99(6):671\u20133.","journal-title":"Arch Dermatol"},{"issue":"12","key":"654_CR20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1600-0560.2010.01612.x","volume":"37","author":"SH Kardaun","year":"2010","unstructured":"Kardaun SH, Kuiper H, Fidler V, Jonkman MF. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol. 2010;37(12):1220\u20139.","journal-title":"J Cutan Pathol"},{"issue":"3","key":"654_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","volume":"74","author":"K Sugiura","year":"2014","unstructured":"Sugiura K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci. 2014;74(3):187\u201392.","journal-title":"J Dermatol Sci"},{"issue":"9","key":"654_CR22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-4362.2003.01998.x","volume":"42","author":"SE Chang","year":"2003","unstructured":"Chang SE, Kim HH, Choi JH, Sung KJ, Moon KC, Koh JK. Impetigo herpetiformis followed by generalized pustular psoriasis: more evidence of same disease entity. Int J Dermatol. 2003;42(9):754\u20135.","journal-title":"Int J Dermatol"},{"issue":"7","key":"654_CR23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei X-Y, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"654_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1744666X.2019.1708193","volume":"16","author":"S Kharawala","year":"2020","unstructured":"Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Rev Clin Immunol. 2020;16(3):239\u201352.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"654_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555766871","volume":"76","author":"A Ohkawara","year":"1996","unstructured":"Ohkawara A, Yasuda H, Kobayashi H, Inaba Y, Ogawa H, Hashimoto I, et al. Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol. 1996;76(1):68\u201371.","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"654_CR26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","volume":"32","author":"KM Hoegler","year":"2018","unstructured":"Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol. 2018;32(10):1645\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"654_CR27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2009.09348.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Molin S, Ruebsam K, Weisenseel P, Ruzicka T, Prinz JC. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Br J Dermatol. 2009;161(4):964\u20136.","journal-title":"Br J Dermatol"},{"issue":"Suppl. 12","key":"654_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1976.tb02274.x","volume":"94","author":"H Baker","year":"1976","unstructured":"Baker H. Corticosteroids and pustular psoriasis. Br J Dermatol. 1976;94(Suppl. 12):83\u20138.","journal-title":"Br J Dermatol"},{"key":"654_CR29","first-page":"131","volume":"6","author":"KE Benjegerdes","year":"2016","unstructured":"Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131\u201344.","journal-title":"Psoriasis (Auckl)."},{"issue":"10","key":"654_CR30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/exd.13699","volume":"27","author":"A Boehner","year":"2018","unstructured":"Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis: a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol. 2018;27(10):1067\u201377.","journal-title":"Exp Dermatol"},{"issue":"5","key":"654_CR31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/bjd.14627","volume":"175","author":"A Khemis","year":"2016","unstructured":"Khemis A, Cavali\u00e9 M, Montaudi\u00e9 H, Lacour J-P, Passeron T. Rebound pustular psoriasis after brodalumab discontinuation. Br J Dermatol. 2016;175(5):1065\u20136.","journal-title":"Br J Dermatol"},{"issue":"2","key":"654_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40257-019-00492-0","volume":"21","author":"T Takeichi","year":"2020","unstructured":"Takeichi T, Akiyama M. Generalized pustular psoriasis: clinical management and update on autoinflammatory aspects. Am J Clin Dermatol. 2020;21(2):227\u201336.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"654_CR33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-4362.1997.00170.x","volume":"36","author":"YK Tay","year":"1997","unstructured":"Tay YK, Tham SN. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases. Int J Dermatol. 1997;36(4):266\u201371.","journal-title":"Int J Dermatol"},{"issue":"4","key":"654_CR34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaci.2014.09.043","volume":"135","author":"S Hussain","year":"2015","unstructured":"Hussain S, Berki DM, Choon S-E, Burden AD, Allen MH, Arostegui JI, et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol. 2015;135(4):1067\u201370.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 1","key":"654_CR35","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","volume":"295","author":"Y Umezawa","year":"2003","unstructured":"Umezawa Y, Ozawa A, Kawasima T, Shimizu H, Terui T, Tagami H, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295(Suppl. 1):S43\u201354.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"654_CR36","doi-asserted-by":"crossref","first-page":"e14814","DOI":"10.1111\/dth.14814","volume":"34","author":"C Kromer","year":"2021","unstructured":"Kromer C, Loewe E, Schaarschmidt M-L, Pinter A, Gerdes S, Herr R, et al. Drug survival in the treatment of generalized pustular psoriasis: a retrospective multicenter study. Dermatol Ther. 2021;34(2):e14814.","journal-title":"Dermatol Ther"},{"issue":"2","key":"654_CR37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13555-021-00493-0","volume":"11","author":"B Strober","year":"2021","unstructured":"Strober B, Kotowsky N, Medeiros R, Mackey RH, Harrold LR, Valdecantos WC, et al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of Corrona Registry dermatologists. Dermatol Ther (Heidelb). 2021;11(2):529\u201341.","journal-title":"Dermatol Ther (Heidelb)."},{"key":"654_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.008","author":"H Miyachi","year":"2021","unstructured":"Miyachi H, Konishi T, Kumazawa R, Matsui H, Shimizu S, Fushimi K, et al. Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol. 2021. https:\/\/doi.org\/10.1016\/j.jaad.2021.06.008.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"654_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1744666X.2019.1708193","volume":"16","author":"S Kharawala","year":"2020","unstructured":"Kharawala S, Golembesky AK, Bohn RL, Esser D. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Exp Rev Clin Immunol. 2020;16(3):239\u201352.","journal-title":"Exp Rev Clin Immunol."},{"issue":"2","key":"654_CR40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.1969.tb15995.x","volume":"81","author":"TJ Ryan","year":"1969","unstructured":"Ryan TJ, Baker H. Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis: evaluation and prognosis based on the study of 104 cases. Br J Dermatol. 1969;81(2):134\u201345.","journal-title":"Br J Dermatol"},{"issue":"9","key":"654_CR41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/1346-8138.13306","volume":"43","author":"S Imafuku","year":"2016","unstructured":"Imafuku S, Honma M, Okubo Y, Komine M, Ohtsuki M, Morita A, et al. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: a 52-week analysis from phase III open-label multicenter Japanese study. J Dermatol. 2016;43(9):1011\u20137.","journal-title":"J Dermatol"},{"issue":"8367","key":"654_CR42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(84)90196-X","volume":"1","author":"HL Sofen","year":"1984","unstructured":"Sofen HL, Moy RL, Lowe NJ. Treatment of generalised pustular psoriasis with isotretinoin. Lancet. 1984;1(8367):40.","journal-title":"Lancet"},{"issue":"10","key":"654_CR43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archderm.1985.01660100077019","volume":"121","author":"RL Moy","year":"1985","unstructured":"Moy RL, Kingston TP, Lowe NJ. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. Arch Dermatol. 1985;121(10):1297\u2013301.","journal-title":"Arch Dermatol"},{"issue":"9","key":"654_CR44","first-page":"580","volume":"42","author":"I Marhold","year":"1991","unstructured":"Marhold I, Duschet P, Schwarz T, Gschnait F. Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis. Hautarzt. 1991;42(9):580\u20133.","journal-title":"Hautarzt"},{"issue":"5","key":"654_CR45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1525-1470.2007.00524.x","volume":"24","author":"H Al-Shobaili","year":"2007","unstructured":"Al-Shobaili H, Al-Khenaizan S. Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol. 2007;24(5):563\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"654_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/11586900-000000000-00000","volume":"12","author":"J Borges-Costa","year":"2011","unstructured":"Borges-Costa J, Silva R, Gon\u00e7alves L, Filipe P, de Almeida LS, Marques GM. Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients. Am J Clin Dermatol. 2011;12(4):271\u20136.","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl. 3","key":"654_CR47","first-page":"24","volume":"33","author":"G Hela","year":"2019","unstructured":"Hela G, Emna B, Mariem N, Noura B, Sonia B, Abderrahmen M, et al. Generalized pustular psoriasis in the south of Tunisia: 44 cases. J Eur Acad Dermatol Venereol. 2019;33(Suppl. 3):24\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"654_CR48","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.18473","volume":"182","author":"Y-W Huang","year":"2020","unstructured":"Huang Y-W, Tsai T-F. Juvenile-onset pustular psoriasis: case series and literature review. Br J Dermatol. 2020;182(3):816\u20137.","journal-title":"Br J Dermatol"},{"issue":"5","key":"654_CR49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/pde.12296","volume":"31","author":"S Popadic","year":"2014","unstructured":"Popadic S, Nikolic M. Pustular psoriasis in childhood and adolescence: a 20-year single-center experience. Pediatr Dermatol. 2014;31(5):575\u20139.","journal-title":"Pediatr Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00654-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00654-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00654-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T02:28:12Z","timestamp":1700101692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00654-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00654-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"28 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been published as part of a journal supplement wholly funded by Boehringer Ingelheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"Medical writing support was funded by Boehringer Ingelheim.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Siew Eng Choon has received consulting fees from AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Sanofi, and UCB. Alexander Navarini has served as a consultant and advisor and\/or received speaking fees and\/or grants and\/or served as an investigator in clinical trials for AbbVie, Almirall, Amgen, Biomed, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, GlaxoSmithKline, LEO Pharma, Janssen-Cilag, MSD, Novartis, Pfizer, Pierre Fabre Pharma, Regeneron, Sandoz, Sanofi, and UCB. Andreas Pinter has served as an advisor and\/or speaker and\/or received grants and\/or served as an investigator for AbbVie, Almirall Hermal, Amgen, Biogen, Boehringer Ingelheim, Celgene, GlaxoSmithKline, Eli Lilly, Galderma, Hexal, Janssen, LEO Pharma, MC2, Medac, Merck Serono, Mitsubishi, MSD, Novartis, Pascoe, Pfizer, Tigercat Pharma, Regeneron, Roche, Sandoz Biopharmaceuticals, Sanofi Genzyme, Schering-Plough, and UCB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients provided their consent to publish their cases. The authors (SEW and AP) express their gratitude to their patients for providing consent.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The sponsor of the supplement and all authors identified and discussed the concept for each chapter and the supplement as a whole; further development of each review article was at the direction of the authors, who provided guidance to OPEN Health Communications on the content of the article, critically revised the work, and approved the content for publication.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}